Ayele Teklie Mengie, Abebe Endeshaw Chekol, Muche Zelalem Tilahun, Agidew Melaku Mekonnen, Yimer Yohannes Shumet, Addis Getu Tesfaw, Baye Nega Dagnaw, Kassie Achenef Bogale, Alemu Muluken Adela, Yiblet Tesfagegn Gobezie, Tiruneh Gebrehiwot Ayalew, Dagnew Samuel Berihun, Moges Tilaye Arega, Tadesse Tesfaye Yimer, Zelalem Amien Ewnetei
Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Department of Medical Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Heliyon. 2023 May 29;9(6):e16654. doi: 10.1016/j.heliyon.2023.e16654. eCollection 2023 Jun.
BACKGROUND: Even though numerous conventional anti-diarrheal agents are available, the inherent toxicities of the drugs urge the search for alternative drugs that are safe and effective. OBJECTIVE: To evaluate the anti-diarrheal activity of crude extract and solvent fractions of leaves. MATERIALS AND METHODS: The were macerated using absolute methanol and then fractionated using solvents of different polarity indexes. For antidiarrheal activity evaluation of the crude extract and solvent fraction, castor oil-induced diarrhea, castor oil-induced anti-enteropolling, and intestinal transit models were used. One-way analysis of variance was used to analyze the data, followed by a Tukey post-test. The standard and negative control groups were treated with loperamide and 2% tween 80 respectively. RESULTS: A significant (p˂0.01) reduction in the frequency of wet stools and watery content of diarrhea, intestinal motility, intestinal fluid accumulation, and delaying the onset of diarrhea as compared with controls were observed in mice treated with 200 mg/kg and 400 mg/kg methanol crude extract. However the effect increased dose-dependently, and the 400 mg/kg methanol crude extract produced a comparable effect with the standard drug in all models. Amongst the solvent fractions, n-BF significantly delayed the time of diarrheal onset and reduced the frequency of defecation, and intestinal motility at doses of 200 mg/kg and 400 mg/kg. Furthermore, the maximum percentage inhibition of intestinal fluid accumulation was observed in mice treated with 400 mg/kg n-butanol extract (p˂0.01; 61.05%). CONCLUSIONS: supports
背景:尽管有许多传统的抗腹泻药物,但这些药物固有的毒性促使人们寻找安全有效的替代药物。 目的:评估树叶粗提物和溶剂提取物的抗腹泻活性。 材料与方法:将树叶用无水甲醇浸渍,然后用不同极性指数的溶剂进行分离。对于粗提物和溶剂提取物的抗腹泻活性评估,采用蓖麻油诱导腹泻、蓖麻油诱导抗肠推进和肠道转运模型。采用单因素方差分析对数据进行分析,随后进行Tukey事后检验。标准对照组和阴性对照组分别用洛哌丁胺和2%吐温80处理。 结果:与对照组相比,用200mg/kg和400mg/kg甲醇粗提物处理的小鼠,其湿粪频率、腹泻水样含量、肠道蠕动、肠液积聚均显著降低(p˂0.01),腹泻发作延迟。然而,这种效果呈剂量依赖性增加,400mg/kg甲醇粗提物在所有模型中产生的效果与标准药物相当。在溶剂提取物中,正丁醇提取物在200mg/kg和400mg/kg剂量下显著延迟腹泻发作时间,降低排便频率和肠道蠕动。此外,在接受400mg/kg正丁醇提取物处理的小鼠中观察到肠液积聚的最大抑制百分比(p˂0.01;61.05%)。 结论:支持
Evid Based Complement Alternat Med. 2022-5-9
Evid Based Complement Alternat Med. 2024-7-12
Evid Based Complement Alternat Med. 2022-5-26
J Pharmacopuncture. 2025-6-30
Evid Based Complement Alternat Med. 2022-8-31
Lab Anim (NY). 2021-11
ACS Omega. 2021-6-14
Pediatr Infect Dis J. 2021-7-1
Int J Surg. 2019-10-15
BMC Complement Altern Med. 2019-7-11
Evid Based Complement Alternat Med. 2018-2-20
Biomed Pharmacother. 2017-12-6